Key facts
- It has raised $9.7M across 1 recorded rounds; the latest was Early Stage VC ($5.5M) in Jan 2026.
- Notable investors include Pareto Holdings, 1/1 Capital, McArthur Capital, Rankin Ventures, Joshua Rosenthal — 6 tracked in total.
- AgelessRX has filed 1 Form D with the SEC, most recently Mar 2026 ($5.5M sold to 32 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for AgelessRX
Funding rounds
1 roundsAbout AgelessRX
Operator of a telehealth e-commerce platform intended to provide longevity prescriptions online. The company offers direct access to safe prescription therapies with a doctor's approval and helps people live longer, healthier lives, by offering prescription therapies shown to safely lower the risk of age-related diseases, enabling patients to live a longer and healthier lives.
- Sector
- Healthcare
- HQ
- Ann Arbor, MI, United States
- Founded
- 2019
- Employees
- 103
- Website
- agelessrx.com/
- Ownership
- Privately Held (backing)
AgelessRX doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in AgelessRX shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on AgelessRX in its N-PORT filings yet. We sweep new filings monthly.